Todos Medical Acquires Distribution Rights to SARS-CoV-2 Rapid Point-of-Care Antigen Test and Rapid Point-of-Care PCR Test

    NEXT STORY
    Outlook Therapeutics Reports Financial Results for the Third Quarter of Fiscal Year 2020 and Provides Corporate Update
    PREV STORY
    Cancer Genetics Reports Second Quarter 2020 Financial Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    New Study Demonstrates the Ability of myPath® Melanoma to Accurately Classify Lesions Ruled Indeterminate by Standard Pathological Assessment

    author_avatar
    NASDAQ Market News

    Chembio Diagnostics Names John Potthoff, Ph.D. to its Board of Directors

    MEDFORD, N.Y., May 16, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in ...

    author_avatar
    NASDAQ Market News

    Radius Health, Inc. Provides Abaloparatide Business Update

    author_avatar
    NASDAQ Market News